TNFRSF11B and Hutchinson-Gilford progeria syndrome: If confirmed, HGPS patients with decreased levels of OPG may actually profit from the treatment with recombinant osteoprotegerin which was shown to decrease bone resorption in patients with Juvenile Paget disease [63].